ReviewCureus2025
Consensus to Conquer Challenges in Influenza Immunization in Pulmonology Practice in India: Proceedings of the Congregation on Influenza Vaccination in Chronic Lung Diseases (CIRCLE) Expert Committee Meet.
Review in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
20 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Influenza remains a major health concern, especially for patients with chronic respiratory diseases such as asthma and chronic obstructive pulmonary disease (COPD). Despite clear evidence of its benefits, annual influenza vaccination rates in India remain critically low, particularly among high-risk populations and healthcare professionals (HCPs). Key barriers include misinformation, lack of provider recommendation, and absence of structured vaccination programs. The year-round circulation of influenza in India supports the use of both Northern Hemisphere (NH) and Southern Hemisphere (SH) vaccines, depending on the timing. Patients should be vaccinated with the latest NH or SH strain whenever they present for immunization. Recent guidelines favor trivalent vaccines due to the absence of the B/Yamagata strain. A multi-pronged strategy involving HCP advocacy, public education, improved infrastructure, and policy support is essential to improve vaccine uptake and reduce influenza-related morbidity and mortality.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.